Measure Motivate Sustain

MetreAce is a scientifically proven, easy-to-use, noninvasive breath acetone measurement device delivering metabolic health insights with the accuracy and precision of a blood BHB ketone test at a fraction of the cost*

MetreAce pairs with our iOS app to provide a seamless user experience.**

Data You Can Trust

MetreAce is clinical grade

MetreAce is an easy-to-use, accurate, and scientifically proven, breath acetone measurement device.

Metre uses field-tested, proven technology backed by patent-protected intellectual property

At its core, MetreAce is built on the world's leading volatile organic compound (VOC) breath testing platform that has been deployed worldwide in evidentiary applications for over three decades.

Metre innovates with novel approaches to solve difficult engineering challenges

Metre uses technological advancements and proprietary algorithms to provide reliable and accurate scientific measurements.

Understand Your
Users Better

METRE

Get a Demo

About

MetreAce enables a greater frequency of testing, facilitating more reliable feedback and better results

MetreAce's painless and easy-to-use platform allows users on-demand checkups of their metabolic status to see how daily food and activity decisions directly affect their health.

MetreAce provides individualized and actionable data

Our solutions at Metre are never one-size-fits-all. Our device and software respond dynamically to each individual user, empowering them with personalized actionable data that they and their caregivers can use to improve health.

MetreAce is noninvasive and inexpensive

Blood tests are painful and continuous glucose and ketone monitors are invasive. Metre is neither, but it is inexpensive: 1/10 the cost of a blood test!

Meet the Team

Founder & CEO

Sean Ballard

Sean is a founder and the Chief Executive Officer of Metre.

Previously he was Chief Executive Officer and Managing Partner of Eigenvector Capital, a hedge fund focused on algorithmic investing. Prior to founding Eigenvector, Sean was an executive at leading investment firms such as Goldman Sachs and Palestra Capital Management.

Sean serves on the Business Affairs committee of the board of scientific publisher Annual Reviews. He graduated with a BS in Economics from Brigham Young University.

Founder & CTO

Glenn Forrester

Glenn is a founder and the Chief Technology Officer of Metre.

Glenn is a serial entrepreneur who started his first company while he was an undergraduate at Harvard, eventually selling that company to Apple. He has started other successful companies in a wide range of markets including AI, medical devices, data science, education, market research, and cloud-based security.

Senior Scientist

Nicole Ing

Prior to joining the Metre team, Nicole had over ten years of academic research experience. She received her M.S. and Ph.D. in Materials Science at the University of California, Irvine, where she was both a National Science Foundation Graduate Research Fellow and a U.S. Department of Education GANN Fellow, specializing in electrochemical biosensors.

During her postdoctoral research for Sandia National Laboratories, she worked on developing high-throughput analytical chemistry assays for molecular screening.

Kimberly C.

Registered Nurse

Amir M.

Ph.D.